KYGEVVI
NDC 50474-350, doxecitine and doxribtimine, powder, for solution, from UCB, Inc..
- Product NDC
- 50474-350
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219792
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50474-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXECITINE2 g/1
- DOXRIBTIMINE2 g/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50474-350-30 | 50474035030 | 30 PACKET in 1 CARTON (50474-350-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (50474-350-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7d5ce670-9314-4fd7-8b0a-1447910dcf9e
Use it
Look up 50474-350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50474-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50474-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.